Filing Details
- Accession Number:
- 0001104659-12-050217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-20 19:21:04
- Reporting Period:
- 2012-07-18
- Filing Date:
- 2012-07-20
- Accepted Time:
- 2012-07-20 19:21:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1475990 | L John Slebir | 1172 Castro Street Mountain View CA 94040 | Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-07-18 | 6,250 | $6.39 | 10,376 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-18 | 6,250 | $30.36 | 4,126 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-07-18 | 3,750 | $8.74 | 7,876 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-18 | 3,750 | $30.36 | 4,126 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-07-18 | 6,250 | $0.00 | 6,250 | $6.39 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-07-18 | 3,750 | $0.00 | 3,750 | $8.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,750 | 2019-09-04 | No | 4 | M | Direct | |
| 30,916 | 2021-01-21 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2012.
- Includes 1,993 shares acquired under the VIVUS, Inc. Employee Stock Purchase Plan on May 14, 2012.
- Twenty-five percent (25%) of the total number of shares became exercisable on 9/4/2010 and one forty-eighth (1/48th) of the total number of shares become exercisable at the end of each full month thereafter until the option is fully vested on 9/14/2013.
- Twenty-five percent (25%) of the total number of shares became exercisable on 1/21/2012 and one forty-eighth (1/48th) of the total number of shares become exercisable at the end of each full month thereafter until the option is fully vested on 1/21/2015.
Billionaire Hedge Funds
